Krsnaa Diagnostics Limited (KRSNAA) Stock Statistics & Valuation Metrics

Krsnaa Diagnostics Limited has a market cap or net worth of ₹27.06B. The enterprise value is ₹27.56B.

Krsnaa Diagnostics Limited has 32,438,670 shares outstanding. The number of shares has decreased by -2.65% in one year.

Krsnaa Diagnostics Limited’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 6.79%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Krsnaa Diagnostics Limited had revenue of 7.17B and earned 776.08M in profits. Earnings per share was 24.04.

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.

Krsnaa Diagnostics Limited pays an annual dividend of ₹2.5, resulting in a dividend yield of 0.3%

Krsnaa Diagnostics Limited upcoming earnings date is Aug 7, 2025, Before Open (Confirmed).

Krsnaa Diagnostics Limited as a current ratio of 1.36, with Debt / Equity ratio of 23.06%

In the past 12 months, Krsnaa Diagnostics Limited has paid 250.79M in taxes.

Krsnaa Diagnostics Limited EV to EBITDA ratio is 14.41, with an EV/FCF ratio of -69.70.

Krsnaa Diagnostics Limited has ₹684.36M in cash and marketable securities with ₹2.04B in debt, giving a net cash position of ₹1.35B billion.

Gross margin is 54.78%, with operating margin of 14.20%, and net profit margin of 10.82%.

The average price target for Krsnaa Diagnostics Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―